Stay updated on Copanlisib and Nivolumab in Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Copanlisib and Nivolumab in Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Copanlisib and Nivolumab in Lymphoma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Added a Locations section listing trial sites in Alabama, Iowa, Kansas, Kentucky, Minnesota, Missouri, New Hampshire, North Carolina, and Utah. Removed the HHS Vulnerability Disclosure link and updated the page revision to v3.3.3.
    Difference
    0.9%
    Check dated 2025-12-23T10:13:03.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    45 days ago
    Change Detected
    Summary
    Revision label updated from v3.2.0 to v3.3.2 on the page, with no changes to study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T17:07:38.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The page no longer displays a general funding/status notice; this is a site-wide message removal and does not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T15:06:31.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The two screenshots show no changes to core study information (title, NCT03484819, sponsor, eligibility criteria, interventions, and locations) and no new sections or data appear. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T01:34:04.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    - Added a government funding notice and operating status guidance, and updated the version to v3.2.0. - Removed the previous version tag v3.1.0.
    Difference
    2%
    Check dated 2025-10-05T12:51:14.000Z thumbnail image
  9. Check
    102 days ago
    Change Detected
    Summary
    Updated page to version v3.1.0 and removed the topic 'Diffuse large B-cell lymphoma' from resources; this reduces a core topic from the content.
    Difference
    0.3%
    Check dated 2025-09-28T09:33:10.000Z thumbnail image

Stay in the know with updates to Copanlisib and Nivolumab in Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Copanlisib and Nivolumab in Lymphoma Clinical Trial page.